WebNov 29, 2016 · SANTA CRUZ, Calif., Nov. 29, 2016 /PRNewswire/ -- SomaGenics, an RNA-focused biotechnology company, announced expansion of its intellectual property portfolio with issue of two new patents for its RNA analysis technologies (miR-ID ® and RealSeq ®) and European patent protection for its therapeutic short synthetic hairpin RNA (sshRNA) … WebAbout SomaGenics. SomaGenics, Inc. is a privately held company with offices and laboratories located in Santa Cruz, California. We specialize in developing novel RNA …
Acceleration of Diabetic Wound Healing with PHD2- and miR-210 ... - PubMed
WebSergei KAZAKOV, Vice President Discovery Reserch Cited by 1,080 of SomaGenics Inc., Santa Cruz Read 62 publications Contact Sergei KAZAKOV WebCUSTOMER USE AGREEMENT. 1. Terms and Conditions. 1.1 General Terms: When purchasing products (“Products”) or services (“Service”) incorporating SOMAGENICS’ … greece\u0027s political system
SomaGenics, Inc.:Board Members,Advisors,Employees,Team
WebSomaGenics General Information. Description. Provider of biotechnology services intended to develop therapeutic devices to cater to the medical needs. The company's … WebSomaGenics’s headquarters are located at 2161 Delaware Ave Ste E, Santa Cruz, California, 95060, United States How do I contact SomaGenics? SomaGenics Contact Info: Phone … WebTo assess activity and delivery in an impaired wound healing model in diabetic mice, PHD2-targeting sshRNAs and miR-210 antimiRs both alone and in combination were formulated for local delivery to wounds using layer-by-layer (LbL) technology. LbL nanofabrication was applied to incorporate sshRNA into a thin polymer coating on a Tegaderm mesh. greece\\u0027s population 2021